BUB
ABMD

BBVA USA Bancshares’s Abiomed Inc ABMD Stock Holding History

BBVA USA Bancshares’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$515K Sell
1,615
-23
-1% -$7.36K 0.02% 394
2020
Q4 		$531K Buy
1,638
+67
+4% +$18.5K 0.03% 383
2020
Q3 		$434K Buy
1,571
+29
+2% +$8.36K 0.02% 385
2020
Q2 		$372K Buy
1,542
+91
+6% +$18.3K 0.02% 412
2020
Q1 		$211K Buy
+1,451
New +$241K 0.02% 454
2019
Q3 		– Sell
-1,284
Closed -$334K – 516
2019
Q2 		$334K Sell
1,284
-90
-7% -$23.9K 0.02% 431
2019
Q1 		$392K Sell
1,374
-43
-3% -$14.3K 0.02% 397
2018
Q4 		$461K Buy
1,417
+50
+4% +$17.4K 0.03% 344
2018
Q3 		$615K Sell
1,367
-93
-6% -$36.7K 0.04% 351
2018
Q2 		$597K Sell
1,460
-135
-8% -$48.9K 0.04% 338
2018
Q1 		$464K Buy
1,595
+24
+2% +$6.08K 0.03% 379
2017
Q4 		$294K Sell
1,571
-323
-17% -$60.3K 0.02% 458
2017
Q3 		$319K Sell
1,894
-208
-10% -$31.5K 0.02% 442
2017
Q2 		$301K Sell
2,102
-22
-1% -$2.96K 0.02% 454
2017
Q1 		$266K Buy
+2,124
New +$246K 0.02% 482

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BBVA USA Bancshares's ABMD Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Abiomed Inc (ABMD) stake by 1.4% in Q1 2021, selling an estimated $7.36K and leaving 1,615 shares worth $515K. The position accounts for 0.02% of the portfolio, ranked #394.

BBVA USA Bancshares first reported a position in ABMD in Q1 2017 and has held it in 15 quarters since. The position peaked at $615K in Q3 2018. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • BBVA USA Bancshares held 1,615 shares of Abiomed Inc worth $515K as of Q1 2021.
  • BBVA USA Bancshares sold 23 Abiomed Inc shares in Q1 2021, an estimated $7.36K.
  • Abiomed Inc made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #394 holding.
  • BBVA USA Bancshares first reported a position in Abiomed Inc in Q1 2017 and has held it in 15 quarters since.
  • BBVA USA Bancshares's Abiomed Inc position peaked at $615K in Q3 2018.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.